SEC Form 4 · accession 0001140361-16-072722
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Eric Davis
Officer — EVP, General Counsel
Period of report
Jul 14, 2016
Accepted (ET)
Jul 18, 2016 · 6:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 14, 2016 | M | 2,656 | $38.59 | A | 73,325 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Common StockF2,F1 | $38.59 | Jul 14, 2016 | M | 2,656 | D | Nov 22, 2008 | May 21, 2018 | Common Stock | 2,656 | 4,823 | D |
Explanation of responses
- F1Original option grant vests 6/48ths on November 22, 2008, and 1/48th on the 12th day of every month thereafter.
- F2Reflects the number of stock options that remain outstanding from this specific stock grant following the reported transaction.